Lina Alon

Lina Alon, PhD, is a Senior Clinical Scientist in Early Clinical Development-Oncology with over 12 years of postdoctoral research experience. Currently, at Genentech, Lina leads initiatives in developing life-changing therapies and improving diagnostics. Previously, Lina has held roles at Bristol Myers Squibb, Medtronic, and The Johns Hopkins University School of Medicine, where they contributed to significant advancements in cancer immunotherapy and clinical evaluation methodologies. Lina's academic credentials include a PhD in Cell and Developmental Biology from Tel Aviv University and a Postdoctoral Fellowship at Johns Hopkins, highlighting a strong foundation in molecular biology and clinical research. Lina is recognized for their analytical skills and proficiency in project management, having successfully published research findings and mentored peers throughout their career.